Jazz Pharmaceuticals plc — Director's Dealing 2014

Dec 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-12-01

Reporting Person: ENRIGHT PATRICK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-01	Ordinary Shares	S	2401	$170.9682	Disposed	360331	Indirect
2014-12-01	Ordinary Shares	S	1208	$171.6468	Disposed	359123	Indirect
2014-12-01	Ordinary Shares	S	3007	$173.0230	Disposed	356116	Indirect
2014-12-01	Ordinary Shares	S	2403	$173.7272	Disposed	353713	Indirect
2014-12-01	Ordinary Shares	S	490	$174.97	Disposed	353223	Indirect
2014-12-01	Ordinary Shares	S	295	$177.10	Disposed	352928	Indirect
2014-12-01	Ordinary Shares	S	48	$170.9608	Disposed	7220	Indirect
2014-12-01	Ordinary Shares	S	25	$171.6516	Disposed	7195	Indirect
2014-12-01	Ordinary Shares	S	60	$173.0278	Disposed	7135	Indirect
2014-12-01	Ordinary Shares	S	48	$173.7288	Disposed	7087	Indirect
2014-12-01	Ordinary Shares	S	10	$174.97	Disposed	7077	Indirect
2014-12-01	Ordinary Shares	S	5	$177.10	Disposed	7072	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	3993	Direct

Footnotes

F1: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $170.40 to $171.39. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F2: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.40 to $171.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F3: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $172.51 to $173.39. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F4: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $173.54 to $174.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F5: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $170.40 to $171.39. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F6: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.40 to $171.99. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F7: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $172.51 to $173.39. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F8: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $173.54 to $174.18. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

F9: The Reporting Person is a managing member of Longitude Capital Partners, LLC, the general partner of each of Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. The Reporting Person disclaims beneficial ownership of the securities of the Issuer held by Longitude Venture Partners, L.P. and Longitude Capital Associates, L.P. except to the extent of his pecuniary interest therein.